Fernando Cabanillas

39.4k citations
478 papers · 27.4k · 6 hit papers · h-index 80

Impact in

Papers in

Fernando Cabanillas

467 papers receiving 26.0k citations

Fernando Cabanillas's Hit Papers

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma 2002 · 913 citations
9130+15+30Years since publication50010001.5k2.0k2.5k

Peers

Fernando Cabanillas
Comparison fields: 5 of 132
  • Pathology and Forensic Medicine 17.1k
  • Genetics 6.4k
  • Oncology 10.7k
  • Neurology 3.8k
  • Hematology 2.6k
Replace Richard I. Fisher with:
Richard I. Fisher United States
Julie M. Vose United States
Jamés O. Armitage United States
Bertrand Coiffier France
Andreas Engert Germany
Andrew D. Zelenetz United States
Gilles Salles France
Bruce D. Cheson United States
Christian Gisselbrecht France
Emanuele Zucca Switzerland
Fernando Cabanillas relative to Richard I. Fisher United States Richard I. Fisher's profile →
Citations per field
00.5×1.5×
Richard I. Fisher · 1×
Citations per year

Countries citing papers authored by Fernando Cabanillas

Since Specialization
Citations

This map shows the geographic impact of Fernando Cabanillas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Cabanillas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Cabanillas more than expected).

Fields of papers citing papers by Fernando Cabanillas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Cabanillas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Cabanillas. The network helps show where Fernando Cabanillas may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando Cabanillas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Cabanillas Line = papers co-authored together Fernando Cabanillas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 478 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Hit paper breakdown →
19992881
2
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Hit paper breakdown →
19982249
3
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
Hit paper breakdown →
2002913
4
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Hit paper breakdown →
1987669
5
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
Hit paper breakdown →
1988500
6 2004436
7
Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma
Hit paper breakdown →
1980434
8 2006400
9 2005400
10 1987363
11 1994358
12 1998310
13 1998285
14 2001276
15 2001238
16 1982227
17 1998226
18 1996226
19 1987206
20 1999200

About Fernando Cabanillas

Fernando Cabanillas is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Pulmonary and Respiratory Medicine, having authored 478 papers that have together received 27.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (340 papers), Chronic Lymphocytic Leukemia Research (111 papers), Viral-associated cancers and disorders (78 papers), CNS Lymphoma Diagnosis and Treatment (62 papers), Lung Cancer Treatments and Mutations (40 papers), Acute Lymphoblastic Leukemia research (29 papers), Cancer Treatment and Pharmacology (24 papers) and Cutaneous lymphoproliferative disorders research (23 papers). The work is most often cited by research in Pathology and Forensic Medicine (17.1k citations), Genetics (6.4k citations), Oncology (10.7k citations), Neurology (3.8k citations) and Hematology (2.6k citations). Fernando Cabanillas has collaborated with scholars based in United States, Puerto Rico and Greece. Frequent co-authors include Peter McLaughlin, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Anas Younes, F Swan, William Pugh, Andreas H. Sarris, Chul S. Ha and Antonio J Grillo-López. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact